Your browser doesn't support javascript.
loading
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Tanaka, Norio; Mori, Seiichi; Kiyotani, Kazuma; Ota, Yuki; Gotoh, Osamu; Kusumoto, Shigeru; Nakano, Nobuaki; Suehiro, Youko; Ito, Asahi; Choi, Ilseung; Ohtsuka, Eiichi; Hidaka, Michihiro; Nosaka, Kisato; Yoshimitsu, Makoto; Imaizumi, Yoshitaka; Iida, Shinsuke; Utsunomiya, Atae; Noda, Tetsuo; Nishikawa, Hiroyoshi; Ueda, Ryuzo; Ishida, Takashi.
Afiliação
  • Tanaka N; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research.
  • Mori S; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research. seiichi.mori@jfcr.or.jp.
  • Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research.
  • Ota Y; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research.
  • Gotoh O; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.
  • Nakano N; Department of Hematology, Imamura General Hospital.
  • Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Centre; Department of Cell Therapy National Hospital Organization Kyushu Cancer Centre.
  • Ito A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.
  • Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Centre.
  • Ohtsuka E; Department of Hematology, Oita Prefectural Hospital.
  • Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center.
  • Nosaka K; Department of Hematology, Kumamoto University Hospital.
  • Yoshimitsu M; Department of Hematology and Rheumatology, Kagoshima University Graduate School of Medical and Dental Sciences.
  • Imaizumi Y; Department of Hematology, Nagasaki University Hospital.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital.
  • Noda T; Cancer Institute, Japanese Foundation for Cancer Research.
  • Nishikawa H; Department of Immunology, Nagoya University Graduate School of Medicine; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center.
  • Ueda R; Department of Immunology, Nagoya University Graduate School of Medicine; Department of Tumor Immunology, Aichi Medical University School of Medicine.
  • Ishida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences; Department of Immunology, Nagoya University Graduate School of Medicine. itakashi@med.nagoya-u.ac.jp.
Haematologica ; 107(10): 2418-2431, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35417939
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Linfoma Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Linfoma Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article